Source: Independent Institute
by Raymond J March
“Private companies—whether making medical goods or anything else — flourish or fail by assessing risk well. The FDA doesn’t face that discipline. The agency’s only real power is to remove products from the market or stop them from entering it. That is a blunt instrument applied to an incredibly dynamic market for medical goods. More importantly, accepting risk is a matter of personal preference and available alternatives — circumstances that differ for every patient and cannot be aggregated into a one-size-fits-all standard without discarding what makes medical treatment effective in the first place.” (06/16/26)
https://www.independent.org/article/2026/06/16/fda-risk-problem/